Peripheral chemokine levels in women with recurrent major depression with suicidal ideation

Detalhes bibliográficos
Autor(a) principal: Grassi-Oliveira,Rodrigo
Data de Publicação: 2012
Outros Autores: Brieztke,Elisa, Teixeira,Antônio, Pezzi,Júlio Carlos, Zanini,Márcio, Lopes,Rodrigo Pestana, Bauer,Moisés Evandro
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000100013
Resumo: OBJECTIVE: To compare serum levels of MCP-1/CCL2, RANTES/CCL5, and Eotaxin/CCL11 between female patients with recurrent major depressive disorder (MDD) and healthy controls, verifying if there is a difference in the levels of these mediators between those with or without current suicidal ideation. METHODS: Thirty female outpatients with recurrent MDD were divided in two groups accordingly the presence or absence of suicidal ideation. These groups were compared with 16 healthy controls. Serum levels of MCP-1/CCL2, RANTES/CCL5, and Eotaxin/CCL11 were determined. Depression severity was evaluated by Beck Depression Inventory (BDI). Suicidal ideation was assessed by SCID-I and BDI. RESULTS: Patients with recurrent MDD and healthy controls did not differ in age, socioeconomic status, and education. All patients reported high scores of BDI (mean, SD, n; 29.75, 10.55, 28). Multivariable analysis of covariance adjusted for age and BMI showed that MDD patients with suicidal ideation presented lower levels of MCP-1/ CCL2 and RANTES/CCL5 (p < 0.001) and higher levels of Eotaxin/CCL11 (p = 0.04) compared to healthy controls. These differences remained significant after adjusting for depression severity. CONCLUSION: The findings of this study indicated that the presence of recurrent MDD with suicidal ideation is associated with differences in inflammatory chemokines when compared to those without suicidal ideation.
id ABP-1_cac056c708ea1fc599c87f487c2997a0
oai_identifier_str oai:scielo:S1516-44462012000100013
network_acronym_str ABP-1
network_name_str Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
repository_id_str
spelling Peripheral chemokine levels in women with recurrent major depression with suicidal ideationSuicideSuicidal IdeationChemokinesCytokinesMajor Depressive DisorderMood DisordersInflammationImmunityOBJECTIVE: To compare serum levels of MCP-1/CCL2, RANTES/CCL5, and Eotaxin/CCL11 between female patients with recurrent major depressive disorder (MDD) and healthy controls, verifying if there is a difference in the levels of these mediators between those with or without current suicidal ideation. METHODS: Thirty female outpatients with recurrent MDD were divided in two groups accordingly the presence or absence of suicidal ideation. These groups were compared with 16 healthy controls. Serum levels of MCP-1/CCL2, RANTES/CCL5, and Eotaxin/CCL11 were determined. Depression severity was evaluated by Beck Depression Inventory (BDI). Suicidal ideation was assessed by SCID-I and BDI. RESULTS: Patients with recurrent MDD and healthy controls did not differ in age, socioeconomic status, and education. All patients reported high scores of BDI (mean, SD, n; 29.75, 10.55, 28). Multivariable analysis of covariance adjusted for age and BMI showed that MDD patients with suicidal ideation presented lower levels of MCP-1/ CCL2 and RANTES/CCL5 (p < 0.001) and higher levels of Eotaxin/CCL11 (p = 0.04) compared to healthy controls. These differences remained significant after adjusting for depression severity. CONCLUSION: The findings of this study indicated that the presence of recurrent MDD with suicidal ideation is associated with differences in inflammatory chemokines when compared to those without suicidal ideation.Associação Brasileira de Psiquiatria2012-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000100013Brazilian Journal of Psychiatry v.34 n.1 2012reponame:Brazilian Journal of Psychiatry (São Paulo. 1999. Online)instname:Associação Brasileira de Psiquiatria (ABP)instacron:ABP10.1590/S1516-44462012000100013info:eu-repo/semantics/openAccessGrassi-Oliveira,RodrigoBrieztke,ElisaTeixeira,AntônioPezzi,Júlio CarlosZanini,MárcioLopes,Rodrigo PestanaBauer,Moisés Evandroeng2012-06-18T00:00:00Zoai:scielo:S1516-44462012000100013Revistahttp://www.bjp.org.br/ahead_of_print.asphttps://old.scielo.br/oai/scielo-oai.php||rbp@abpbrasil.org.br1809-452X1516-4446opendoar:2012-06-18T00:00Brazilian Journal of Psychiatry (São Paulo. 1999. Online) - Associação Brasileira de Psiquiatria (ABP)false
dc.title.none.fl_str_mv Peripheral chemokine levels in women with recurrent major depression with suicidal ideation
title Peripheral chemokine levels in women with recurrent major depression with suicidal ideation
spellingShingle Peripheral chemokine levels in women with recurrent major depression with suicidal ideation
Grassi-Oliveira,Rodrigo
Suicide
Suicidal Ideation
Chemokines
Cytokines
Major Depressive Disorder
Mood Disorders
Inflammation
Immunity
title_short Peripheral chemokine levels in women with recurrent major depression with suicidal ideation
title_full Peripheral chemokine levels in women with recurrent major depression with suicidal ideation
title_fullStr Peripheral chemokine levels in women with recurrent major depression with suicidal ideation
title_full_unstemmed Peripheral chemokine levels in women with recurrent major depression with suicidal ideation
title_sort Peripheral chemokine levels in women with recurrent major depression with suicidal ideation
author Grassi-Oliveira,Rodrigo
author_facet Grassi-Oliveira,Rodrigo
Brieztke,Elisa
Teixeira,Antônio
Pezzi,Júlio Carlos
Zanini,Márcio
Lopes,Rodrigo Pestana
Bauer,Moisés Evandro
author_role author
author2 Brieztke,Elisa
Teixeira,Antônio
Pezzi,Júlio Carlos
Zanini,Márcio
Lopes,Rodrigo Pestana
Bauer,Moisés Evandro
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Grassi-Oliveira,Rodrigo
Brieztke,Elisa
Teixeira,Antônio
Pezzi,Júlio Carlos
Zanini,Márcio
Lopes,Rodrigo Pestana
Bauer,Moisés Evandro
dc.subject.por.fl_str_mv Suicide
Suicidal Ideation
Chemokines
Cytokines
Major Depressive Disorder
Mood Disorders
Inflammation
Immunity
topic Suicide
Suicidal Ideation
Chemokines
Cytokines
Major Depressive Disorder
Mood Disorders
Inflammation
Immunity
description OBJECTIVE: To compare serum levels of MCP-1/CCL2, RANTES/CCL5, and Eotaxin/CCL11 between female patients with recurrent major depressive disorder (MDD) and healthy controls, verifying if there is a difference in the levels of these mediators between those with or without current suicidal ideation. METHODS: Thirty female outpatients with recurrent MDD were divided in two groups accordingly the presence or absence of suicidal ideation. These groups were compared with 16 healthy controls. Serum levels of MCP-1/CCL2, RANTES/CCL5, and Eotaxin/CCL11 were determined. Depression severity was evaluated by Beck Depression Inventory (BDI). Suicidal ideation was assessed by SCID-I and BDI. RESULTS: Patients with recurrent MDD and healthy controls did not differ in age, socioeconomic status, and education. All patients reported high scores of BDI (mean, SD, n; 29.75, 10.55, 28). Multivariable analysis of covariance adjusted for age and BMI showed that MDD patients with suicidal ideation presented lower levels of MCP-1/ CCL2 and RANTES/CCL5 (p < 0.001) and higher levels of Eotaxin/CCL11 (p = 0.04) compared to healthy controls. These differences remained significant after adjusting for depression severity. CONCLUSION: The findings of this study indicated that the presence of recurrent MDD with suicidal ideation is associated with differences in inflammatory chemokines when compared to those without suicidal ideation.
publishDate 2012
dc.date.none.fl_str_mv 2012-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000100013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000100013
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1516-44462012000100013
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
dc.source.none.fl_str_mv Brazilian Journal of Psychiatry v.34 n.1 2012
reponame:Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
instname:Associação Brasileira de Psiquiatria (ABP)
instacron:ABP
instname_str Associação Brasileira de Psiquiatria (ABP)
instacron_str ABP
institution ABP
reponame_str Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
collection Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
repository.name.fl_str_mv Brazilian Journal of Psychiatry (São Paulo. 1999. Online) - Associação Brasileira de Psiquiatria (ABP)
repository.mail.fl_str_mv ||rbp@abpbrasil.org.br
_version_ 1754212555597807616